Skip to main content
Caplight Logo









Neuralace Medical

Neuralace Medical

Private
San Marcos, CaliforniaHealthcare & Life Scienceshttps://neuralacemedical.com/

Last Round

Seed

May 30, 2023

Total Funding Raised

$5.9M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Neuralace Medical is a medical device company that develops non-invasive neuromodulation technology for the treatment of chronic neuropathic pain.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT

Business Model

B2B

Customer Profile

Hardware Sales, Government Contracts

AI Layer

Non-AI

Keywords

neuromodulationmagnetic peripheral nerve stimulationmPNSchronic pain managementneuropathic painnon-invasive medical devicepain relief technologydiabetic neuropathy treatmentdrug-free pain reliefpain management clinicmedical device salesnerve stimulationpain technon-opioid pain treatmentB2G

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Neuralace Medical Comparables

Compare Neuralace Medical with similar companies based on industry and business-model similarity.

Neuralace Medical comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Medtronic
79%
DyAnsys, Inc.
78%
Nervonik
77%

Neuralace Medical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMay 30, 2023
SeedJun 19, 2019
GrantOct 24, 2018
SeedMar 15, 2017

Neuralace Medical Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 16, 2026

    Grew 20% QoQ, from 20 to 24 employees.

  • Apr 19, 2026

    Monthly visitors increased 31% MoM.

Neuralace Medical Filings

Explore SEC and related filing metadata, where available.

Neuralace Medical filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Neuralace Medical's valuation, stock price, and market status.

Is Neuralace Medical a public or private company?

Neuralace Medical is a private company.

What is the current stock price of Neuralace Medical?

Neuralace Medical is a private company with no public stock price. No recent secondary market data is available.

How much is Neuralace Medical worth (valuation)?

Valuation information for Neuralace Medical is not publicly available.

Can I buy Neuralace Medical stock?

Neuralace Medical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Neuralace Medical's last funding round?

Neuralace Medical's most recent funding round was Seed on May 25, 2023.

Who are the main investors in Neuralace Medical?

Key investors in Neuralace Medical include FusionX Ventures.

Will Neuralace Medical IPO soon?

No public IPO plans have been announced for Neuralace Medical.

How can I track Neuralace Medical secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Neuralace Medical's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSan Marcos, California
Employee Range15
Year Founded2011
Last FundingMay 30, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?